These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 25893403)
41. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects. Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541 [TBL] [Abstract][Full Text] [Related]
42. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort. Huda S; Woodhall MR; Vincent A; Heckmann JM Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303 [TBL] [Abstract][Full Text] [Related]
43. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies. Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029 [TBL] [Abstract][Full Text] [Related]
44. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Link J Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782 [TBL] [Abstract][Full Text] [Related]
55. [Expression of IL-21 in the peripheral blood of myasthenia gravis patients and its correlation with anti-AChR-Ab class switch]. Hu B; Tian X; Huang H; Jian A; Ouyang S; Yin W; Duan W; Yang H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):958-63. PubMed ID: 20871161 [TBL] [Abstract][Full Text] [Related]
56. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539 [TBL] [Abstract][Full Text] [Related]
57. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent. Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288 [TBL] [Abstract][Full Text] [Related]
59. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile. Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385 [TBL] [Abstract][Full Text] [Related]
60. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review. Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]